Education
About Us
Working with TipRanks
Follow Us
SynBiotic SE (DE:SBX)
:SBX
SBX Stock Chart & Stats
Day’s Range― - ―
52-Week Range€2.55 - €9.26
Previous CloseN/A
Volume3.88K
Average Volume (3M)2.78K
Market Cap
€17.72M
Enterprise Value€46.70M
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.84
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,599,537
10 Day Avg. Volume2,618
30 Day Avg. Volume2,784
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)1.91
Price to Sales (P/S)0.00
P/FCF Ratio-5.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
SBX FAQ
What was SynBiotic SE’s price range in the past 12 months?
SynBiotic SE lowest stock price was €2.55 and its highest was €9.26 in the past 12 months.
What is SynBiotic SE’s market cap?
SynBiotic SE’s market cap is €17.72M.
When is SynBiotic SE’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SynBiotic SE’s earnings last quarter?
Currently, no data Available
Is SynBiotic SE overvalued?
According to Wall Street analysts SynBiotic SE’s price is currently Overvalued.
Does SynBiotic SE pay dividends?
SynBiotic SE does not currently pay dividends.
What is SynBiotic SE’s EPS estimate?
SynBiotic SE’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SynBiotic SE have?
SynBiotic SE has 5,599,537 shares outstanding.
What happened to SynBiotic SE’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SynBiotic SE?
Currently, no hedge funds are holding shares in DE:SBX
SynBiotic SE Stock Smart Score
Company Description
SynBiotic SE
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.